Team Firsts

Unmatched for Industry Firsts

The innovations of the members of Piedmont’s leadership team have transformed the field of companion animal veterinary medicine and resulted in a long list of industry firsts:

  • First and only single treatment topical for otitis externa in dogs [CLARO® (florfenicol, terbinafine, mometasone furoate)]
  • First soft-chew medicinal platform with three global patents [QUELLIN™ (carprofen)]
  • First oral once-a-month flea control for dogs and cats [PROGRAM® (lufenuron)]
  • First to reach $175 million in sales for a companion animal product [PROGRAM® Tablets]
  • First TV campaign supporting an FDA veterinary prescription product [PROGRAM®]
  • First six-month injectable for flea control in cats [PROGRAM® 6-month injectable]
  • First combination oral product for flea and heartworm control [SENTINEL® (milbemycin oxime/lufenuron)]
  • First FDA approval of an oral adulticidal flea control [CAPSTAR® (nitenpyram)]
  • First water-based formulation of ivermectin [ACAREXX® (ivermectin)]
  • First and only treatment for Addison’s disease in dogs approved by FDA [PERCORTEN-V® (DOCP)]
  • First and only insulin for cats approved by FDA and only recombinant insulin approved in animal health [PROZINC® (protamine zinc recombinant human insulin)]
  • First EPA biopesticide registration for companion animals [RESULTIX®]
  • First topical NSAID product for horses [SURPASS® (1% diclofenac sodium)]
  • First feed-through fly control for horses
    [SOLITUDE IGR®]
ACAREXX, PROZINC, and SURPASS are registered trademarks of Boehringer Ingelheim Vetmedica, Inc.
CAPSTAR, CLOMICALM, DERAMAXX, INTERCEPTOR, MILBEMITE, PROGRAM, and PERCORTEN-V are registered trademarks of Elanco.
QUELLIN, RESULTIX, and CLARO are registered trademarks of Bayer HealthCare AG.
RESULTIX is a registered trademark of Bayer HealthCare AG.
IVERHART, SENTINEL, and VIRBANTEL are registered trademarks of Virbac Corporation.
SOLITUDE IGR is a registered trademark of Zoetis.
img-1st-ribbon